Header Logo

Connection

JAMES C YAO to B7-H1 Antigen

Back to Details
This is a "connection" page, showing publications JAMES C YAO has written about B7-H1 Antigen.
JAMES C YAO
Connection Strength
0.116
B7-H1 Antigen
  1. Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer Discov. 2021 11; 11(11):2738-2747.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.